Alltest BZO300 Rapid Test Panel (Urine)-CLIA Waived

Basic Information

• Brand Name: Alltest BZO300 Rapid Test Panel (Urine)-CLIA Waived
• Primary DI: 06936983114349
• Version / Model: 1
• Catalog Number: DBZ-A114C (300ng)
• Company Name: Hangzhou AllTest Biotech Co., Ltd.
• Labeler DUNS: 543254717
• Distribution Status: In Commercial Distribution
• Device Count in Pkg: 25
• Record Status: Published
• Publish Date: 2026-04-21
• Public Version: 1
• Public Version Date: 2026-04-29
• Public Version Status: New
• Public Device Record Key: 2101dd3d-a939-43ed-8484-0140f97e04c1

Device Description

25T, for FDA CLIA Waived

Device Characteristics

• Single Use: Yes
• Prescription Use (Rx): No
• Over the Counter (OTC): Yes
• Kit: No
• Combination Product: No
• HCT/P: No
• Contains NRL: No
• Not Made with NRL: No
• MRI Safety: Labeling does not contain MRI Safety Information
• Direct Marking Exempt: No
• PM Exempt: No
• Has Serial Number: No
• Has Lot/Batch Number: Yes
• Has Manufacturing Date: No
• Has Expiration Date: Yes
• Has Donation ID: No

Sterilization

• Is Sterile: No
• Sterilization Prior Use: No

Product Codes

Code	Name	Medical Specialty	Regulation #	Device Class
NFV	Test, Benzodiazepine, Over The Counter	Clinical Toxicology	862.3170	2

GMDN Terms

Code	Name	Definition	Implantable	Status
30518	Benzodiazepine group IVD, kit, rapid ICT, clinical	A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of benzodiazepine in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.	No	Active

Identifiers

Type	ID	Issuing Agency	Package Type	Qty per Pkg	Pkg Status	Pkg Discontinue Date
Unit of Use	86936983114345	GS1
Primary	06936983114349	GS1